Hand, Foot, and Mouth Disease: Disease Process and Progression
Hand, foot, and mouth disease (HFMD) is typically a mild, self-limiting viral illness that resolves within 5-7 days, though severe neurological and cardiopulmonary complications can occur, particularly in children under 5 years of age.
Typical Disease Course
Initial Phase (Days 1-2)
- Fever onset: High-grade fever (≥101.3°F) occurs in approximately 67% of cases, with low-grade fever in the remaining 33% 1
- Fever is present in 100% of clinically diagnosed cases 1
- Systemic symptoms may include malaise and irritability
Oral Manifestations (Days 2-3)
- Oral ulcers develop in 100% of cases 1
- Painful ulcers occur in approximately 80% of cases, painless in 20% 1
- These typically appear on the tongue, buccal mucosa, and palate
- Oral lesions often cause difficulty eating and drinking
Cutaneous Manifestations (Days 2-4)
The characteristic rash appears with specific distribution patterns 1:
- Hands: 100% of cases
- Feet: 91% of cases
- Knees: 83% of cases
- Buttocks: 79% of cases
The rash is painful in 75% and itchy in 74% of cases 1
Resolution Timeline
Fever Resolution
- Within 5 days: 59% of patients 1
- 5-7 days: 23% of patients 1
- Remaining cases resolve shortly thereafter
Rash Resolution
Within 7 days (69% of cases) 1:
- Complete resolution: 24%
- Hyperpigmented areas: 24%
- Hypopigmented areas: 15%
- Mild residual lesions: 6%
Oral Ulcer Resolution
Clinical Course Variations by Age
Neonates (≤1 month) present with atypical features 2:
- Lower rates of characteristic rash and herpangina
- Significantly elevated CSF protein with decreased CSF glucose
- Higher rates of meningeal irritation signs (67%) and aseptic meningitis (73%)
- Longer median hospital stay (8 days)
- Relatively benign overall course despite prominent CSF abnormalities
Children 1-3 years (the most affected age group, comprising 63% of cases) 2:
- Highest rate of convulsions (21%)
- Classic presentation with full triad of symptoms
Children >3 years 2:
- Higher rates of intracranial hypertension (24%)
- More prone to neurological complications
Severe Complications (Rare but Critical)
While most cases are benign, severe complications can develop 3, 4:
Neurological Complications
- Aseptic meningitis/encephalitis
- Acute flaccid myelitis (AFM) with rapid limb weakness
- Rhomboencephalitis (particularly with EV-A71)
- Seizures
Cardiopulmonary Complications
- Myocarditis
- Pulmonary edema
- Cardiopulmonary failure (rare but potentially fatal)
Important Clinical Caveat
The disease can progress rapidly to severe complications within 24-48 hours in susceptible individuals, particularly those infected with EV-A71 3, 4. This emphasizes the need for close monitoring during the acute phase, especially in children under 5 years.
Etiological Agents and Their Implications
Coxsackievirus A6 (Cox A6) has emerged as the predominant causative agent, accounting for 86% of RT-PCR confirmed cases 1, followed by Cox A16 and EV-A71 5. Cox A6 has been specifically associated with onychomadesis (nail shedding) occurring weeks after the acute illness 5.
Viral Shedding and Contagion Period
Patients shed virus in stool and respiratory secretions for weeks to months after symptom onset 5. This prolonged shedding period means:
- Children remain potentially contagious well beyond clinical resolution
- Detection of virus in throat/stool samples must be interpreted cautiously regarding acute infection
- Immunocompromised patients can shed virus for years 5
Prognosis
The overall prognosis is excellent with no complications found in the vast majority of uncomplicated cases 1. Complete recovery within 1-2 weeks is typical 6. However, severe cases with neurological involvement can result in long-term morbidity and, rarely, mortality 1, 3.